Inventor · disambiguated record
Tianyang Qi
Also filed as: QI TIANYANG
0 granted patents·7 pending applications·0 citations·filing 2021–2023
Top patents by PatentIndex Score
7 records- 0154US2025295677A1Method for treating cancer by using th-302 alone or in combination with parp inhibitorASCENTAWITS PHARMACEUTICALS LTD·Filed 2023·Application pending·0 cites
- 0249US2023339991A1Hypoxia-activated dna alkylating agent and medical use thereofASCENTAWITS PHARMACEUTICALS LTD·Filed 2021·Application pending·0 cites
- 0349US2025186468A1Method for treating patient with brca-mutated cancerASCENTAWITS PHARMACEUTICALS LTD·Filed 2023·Application pending·0 cites
- 0447US2024316079A1Use of akr1c3-activated compoundOBI PHARMA INC·Filed 2021·Application pending·0 cites
- 0546US2025387419A1Parp inhibitor-resistant patient treated with th-302ASCENTAWITS PHARMACEUTICALS LTD·Filed 2022·Application pending·0 cites
- 0642US2025281514A1Treatment of cancer patients having kras mutationsASCENTAWITS PHARMACEUTICALS LTD·Filed 2022·Application pending·0 cites
- 0740US2024368209A1Gemcitabine anticancer derivative and anticancer pharmaceutical useASCENTAWITS PHARMACEUTICALS LTD·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Tianyang Qi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →